Mon-12-10-2020, 16:48 PM
Maybe worth asking again.
And better still.
Quote:Toronto, ON(November 15, 2017)--Janssen Inc.announced today that Health Canada has approved TREMFYA™ (guselkumab) for the treatment of adults living with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
And better still.
Quote:Toronto, ON, September 10,2020–The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that Health Canada has approved TREMFYA®(guselkumab injection) for adult patients with active psoriatic arthritis (PsA)